NR283 Test Question Bank
I I I
Chapter 20: Neoplasms and Cancer
I I I I
MyNursing Test Banks
I I I I
Chapter I20: INeoplasms Iand
I CancerITest IBank
MULTIPLEICHOICE
1. What I is Ia Ibenign I neoplasm Ioriginating I from Iadipose Itissue Icalled?
a. Adenoma
b. Lipoma
c. Fibrosarcoma
d. Adenocarcinoma
ANS: I B IREF: I550
2. What Iare I malignant I neoplasms Iarising I from Iconnective Itissue Icells Icalled?
a.Carcinomas
b.Sarcomas
c.Melanomas
d.Fibromas
ANS: I B IREF: I550
1
,3. Which Iof Ithe I following I is Ia Icharacteristic Iof Ia Ibenign Itumor?
a. It I is I unencapsulated Iand I invasive.
b. It Iconsists Iof Iundifferentiated Icells.
c. It Iexerts Isystemic Ieffects.
d.Cells Iappear Irelatively I normal.
ANS: I D IREF: I550
4. Which I factor Iprovides Ithe Ibasis I for Ithe I grading Iof I newly Idiagnosed I malignant Itumors?
a. Size Iof Ithe Itumor
b.Number Iof I metastases
c.Degree Iof Idifferentiation Iof Ithe I cells
d.Number Iof I lymph I nodes I involved
ANS: IC IREF: I551
5. AIwarning I sign Iof Ipossible Icancer Iwould Ibe Iany Iof Ithe I following IEXCEPT:
a.persistent, I unusual Ibleeding.
b.a Ichange I in Ibowel I habits.
c.sudden Idevelopment Iof I fever, I nausea, Iand Idiarrhea.
2
,d.a Ichange I in Ishape, Icolor, Ior Isurface Iof Ia Iskin I lesion.
ANS: IC IREF: I552
6. The Icommon I local Ieffects Iof Ian Iexpanding I tumor Imass I include:
1. obstruction Iof Ia Itube Ior Iduct.
2. anemia Iand Iweight I loss.
3. cell Inecrosis Iand I ulceration.
4. tumor I markers I in I the Icirculation.
a.1, I 2
b.1, I3
c.2, I 4
d.3, I4
ANS: I B IREF: I552
7. Which Iof Ithe I following Idoes Iparaneoplastic Isyndrome Irefer I to?
a.The Ieffects Iof Isubstances Isuch Ias I hormones Isecreted Iby Ithe Itumor Icells
b.Severe Iweight I loss Iand Icachexia Iassociated Iwith Iadvanced Icancer
c.The Idecreased Iresistance Ito I infection Iresulting I from I malignant Itumors
d.The Ieffects Iof I multiple I metastatic Itumors
3
, ANS:IAIREF: I553
8. Which Iterm Irefers Ito Ithe Ispread Iof I malignant Icells Ithrough Iblood Iand I lymph Ito Idistant Isites?
a. Invasiveness
b.Seeding
c.Metastasis
d.Systemic Ieffect
ANS: IC IREF: I554
9. One Ireason I for Istaging Ia I malignant Itumor Iat Ithe I time Iof Idiagnosis I is Ito:
a. identify Ithe Ioriginal Icell I from Iwhich Ithe Itumor Ideveloped.
b.locate Iand I identify I the Iprimary Itumor.
c.decide Ithe I initiating I factor I for Ia Iparticular Itumor.
d.determine Ithe Ibest Itreatment Iand Iprognosis.
ANS: I D IREF: I556
10. The Iprocess Iof Icarcinogenesis I usually Ibegins Iwith:
a.exposure Ito Ipromoters Icausing Idysplasia.
b.development Iof Idefective I genes.
c.an I irreversible Ichange I in Ithe Icell I DNA.
4
I I I
Chapter 20: Neoplasms and Cancer
I I I I
MyNursing Test Banks
I I I I
Chapter I20: INeoplasms Iand
I CancerITest IBank
MULTIPLEICHOICE
1. What I is Ia Ibenign I neoplasm Ioriginating I from Iadipose Itissue Icalled?
a. Adenoma
b. Lipoma
c. Fibrosarcoma
d. Adenocarcinoma
ANS: I B IREF: I550
2. What Iare I malignant I neoplasms Iarising I from Iconnective Itissue Icells Icalled?
a.Carcinomas
b.Sarcomas
c.Melanomas
d.Fibromas
ANS: I B IREF: I550
1
,3. Which Iof Ithe I following I is Ia Icharacteristic Iof Ia Ibenign Itumor?
a. It I is I unencapsulated Iand I invasive.
b. It Iconsists Iof Iundifferentiated Icells.
c. It Iexerts Isystemic Ieffects.
d.Cells Iappear Irelatively I normal.
ANS: I D IREF: I550
4. Which I factor Iprovides Ithe Ibasis I for Ithe I grading Iof I newly Idiagnosed I malignant Itumors?
a. Size Iof Ithe Itumor
b.Number Iof I metastases
c.Degree Iof Idifferentiation Iof Ithe I cells
d.Number Iof I lymph I nodes I involved
ANS: IC IREF: I551
5. AIwarning I sign Iof Ipossible Icancer Iwould Ibe Iany Iof Ithe I following IEXCEPT:
a.persistent, I unusual Ibleeding.
b.a Ichange I in Ibowel I habits.
c.sudden Idevelopment Iof I fever, I nausea, Iand Idiarrhea.
2
,d.a Ichange I in Ishape, Icolor, Ior Isurface Iof Ia Iskin I lesion.
ANS: IC IREF: I552
6. The Icommon I local Ieffects Iof Ian Iexpanding I tumor Imass I include:
1. obstruction Iof Ia Itube Ior Iduct.
2. anemia Iand Iweight I loss.
3. cell Inecrosis Iand I ulceration.
4. tumor I markers I in I the Icirculation.
a.1, I 2
b.1, I3
c.2, I 4
d.3, I4
ANS: I B IREF: I552
7. Which Iof Ithe I following Idoes Iparaneoplastic Isyndrome Irefer I to?
a.The Ieffects Iof Isubstances Isuch Ias I hormones Isecreted Iby Ithe Itumor Icells
b.Severe Iweight I loss Iand Icachexia Iassociated Iwith Iadvanced Icancer
c.The Idecreased Iresistance Ito I infection Iresulting I from I malignant Itumors
d.The Ieffects Iof I multiple I metastatic Itumors
3
, ANS:IAIREF: I553
8. Which Iterm Irefers Ito Ithe Ispread Iof I malignant Icells Ithrough Iblood Iand I lymph Ito Idistant Isites?
a. Invasiveness
b.Seeding
c.Metastasis
d.Systemic Ieffect
ANS: IC IREF: I554
9. One Ireason I for Istaging Ia I malignant Itumor Iat Ithe I time Iof Idiagnosis I is Ito:
a. identify Ithe Ioriginal Icell I from Iwhich Ithe Itumor Ideveloped.
b.locate Iand I identify I the Iprimary Itumor.
c.decide Ithe I initiating I factor I for Ia Iparticular Itumor.
d.determine Ithe Ibest Itreatment Iand Iprognosis.
ANS: I D IREF: I556
10. The Iprocess Iof Icarcinogenesis I usually Ibegins Iwith:
a.exposure Ito Ipromoters Icausing Idysplasia.
b.development Iof Idefective I genes.
c.an I irreversible Ichange I in Ithe Icell I DNA.
4
